Immune Checkpoint Inhibitors in HBV-Caused Hepatocellular Carcinoma Therapy

Hepatitis B virus (HBV) infection is the main risk factor for the development of hepatocellular carcinoma (HCC), the most common type of liver cancer, with high incidence and mortality worldwide. Surgery, liver transplantation, and ablation therapies have been used to treat early HBV-caused HCC (HBV...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jin, Hu, Changwei, Xie, Xiaoxiao, Qi, Linzhi, Li, Chuanzhou, Li, Shangze
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10059020/
https://www.ncbi.nlm.nih.gov/pubmed/36992198
http://dx.doi.org/10.3390/vaccines11030614

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10059020/
https://www.ncbi.nlm.nih.gov/pubmed/36992198
http://dx.doi.org/10.3390/vaccines11030614

Ejemplares similares